Suspected Drug-induced Liver Injury Due to 6-Mercaptopurine With a Superimposed SARS-CoV-2 Infection in a Patient With B-ALL
dc.contributor.author | Cablay, Kory | en |
dc.contributor.author | Borowicz, Violet M. | en |
dc.contributor.author | Fulton, Ryan | en |
dc.date.accessioned | 2022-03-02T16:27:47Z | en |
dc.date.available | 2022-03-02T16:27:47Z | en |
dc.date.issued | 2022-01-28 | en |
dc.date.updated | 2022-03-02T16:27:45Z | en |
dc.description.abstract | 6-mercaptopurine is a chemotherapeutic drug that exhibits hepatotoxic effects due to its toxic metabolites. This report describes a case of suspected drug-induced liver injury exacerbated by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A 16-year-old male with very high risk B-cell acute lymphoblastic leukemia was admitted for hyperbilirubinemia 2 months after a 6-mercaptopurine dosage increase and found to have an active SARS-CoV-2 infection. Liver function improved throughout hospitalization and the patient was discharged on allopurinol. Following liver function after a dosage increase of hepatoxic chemotherapy and in a pediatric oncology patient with an active SARS-CoV-2 infection undergoing treatment is vital due to potential liver impact. | en |
dc.description.version | Accepted version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1097/mph.0000000000002407 | en |
dc.identifier.eissn | 1536-3678 | en |
dc.identifier.issn | 1077-4114 | en |
dc.identifier.other | 00043426-900000000-96674 (PII) | en |
dc.identifier.pmid | 35091518 | en |
dc.identifier.uri | http://hdl.handle.net/10919/109008 | en |
dc.language.iso | en | en |
dc.publisher | Wolters Kluwer Health | en |
dc.relation.uri | https://www.ncbi.nlm.nih.gov/pubmed/35091518 | en |
dc.rights | In Copyright | en |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | en |
dc.subject | 1102 Cardiorespiratory Medicine and Haematology | en |
dc.subject | Oncology & Carcinogenesis | en |
dc.title | Suspected Drug-induced Liver Injury Due to 6-Mercaptopurine With a Superimposed SARS-CoV-2 Infection in a Patient With B-ALL | en |
dc.title.serial | Journal of Pediatric Hematology/Oncology | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Journal Article | en |
pubs.organisational-group | /Virginia Tech | en |
pubs.organisational-group | /Virginia Tech/VT Carilion School of Medicine | en |
pubs.organisational-group | /Virginia Tech/VT Carilion School of Medicine/Pediatrics | en |
pubs.organisational-group | /Virginia Tech/VT Carilion School of Medicine/Pediatrics/Pediatric Hematology/Oncology | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- JPHO-21-381.pdf
- Size:
- 84.99 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version